It has been put forward that IL-15 DCs have an optimal antigen-presenting capacity; a recent study by Dubsky et al. has emphasized their potent ability to prime and expand high-avidity tumor antigen-specific CD8+ cytotoxic T lymphocytes [24]. This evidence concerns the gene CD8A and neoplasm.